Literature DB >> 23409790

Particle species dependence of cell survival RBE: Evident and not negligible.

Thomas Friedrich, Marco Durante, Michael Scholz.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23409790     DOI： 10.3109/0284186X.2013.767984

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  6 in total

Review 1.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

2.  Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.

Authors:  John G Eley; Thomas Friedrich; Kenneth L Homann; Rebecca M Howell; Michael Scholz; Marco Durante; Wayne D Newhauser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-16       Impact factor: 7.038

Review 3.  Applications of nanodosimetry in particle therapy planning and beyond.

Authors:  Antoni Rucinski; Anna Biernacka; Reinhard Schulte
Journal:  Phys Med Biol       Date:  2021-12-10       Impact factor: 3.609

4.  New Ions for Therapy.

Authors:  Francesco Tommasino; Emanuele Scifoni; Marco Durante
Journal:  Int J Part Ther       Date:  2016-02-09

5.  Comprehensive track-structure based evaluation of DNA damage by light ions from radiotherapy-relevant energies down to stopping.

Authors:  W Friedland; E Schmitt; P Kundrát; M Dingfelder; G Baiocco; S Barbieri; A Ottolenghi
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 6.  Particle therapy and nanomedicine: state of art and research perspectives.

Authors:  Sandrine Lacombe; Erika Porcel; Emanuele Scifoni
Journal:  Cancer Nanotechnol       Date:  2017-11-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.